More articles from 1.5 Diffuse Parenchymal Lung Disease

The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Tim Sutherland, Paul Beirne, Ann Boardman, Alison Boland, Susie Gillon, Jane Slough

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3902; DOI: 10.1183/13993003.congress-2016.PA3902
Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Michael Kreuter, Felix J.F. Herth, Margarethe Wacker, Peter Hammerl, Conrad Wiederhold, Reiner Leidl, Andreas Hellmann, Michael Pfeifer, Jürgen Behr, Sabine Witt, Dagmar Kauschka, Marcus Mall, Andreas Günther, Philip Markart

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3905; DOI: 10.1183/13993003.congress-2016.PA3905
Rare cause of interstitiel lung disease in children: Pleuroparanchymal fibroelastosis
Nilay Bas Ikizoglu, Emine Atag, Ela Erdem Eralp, Yasemin Gokdemir, Gursu Kiyan, Fazilet Karakoc, Refika Ersu, Bulent Karadag

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3883; DOI: 10.1183/13993003.congress-2016.PA3883
Treatment response in hypersensitivity pneumonitis
Maria Laura Alberti, Francisco Paulin, Martin Eduardo Fernández, Fabián Matías Caro

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3919; DOI: 10.1183/13993003.congress-2016.PA3919
Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts
Ellen Forty, Paul Mercer, Dimitrios Anastasiou, Rachel Chambers

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3893; DOI: 10.1183/13993003.congress-2016.PA3893
Bronchopulmonary dysplasia in children: Prediction and prevention of the mortality at first year
Olga Logvinova, Ganna Senatorova, Alexandr Onikienko, Ekaterina Logvinova

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3884; DOI: 10.1183/13993003.congress-2016.PA3884
Idiopatic fibrosing alveolitis functional respiratory disorders in children
Iulia Rodoman, Svetlana Sciuca, Aliona Cotoman, Rodica Selevestru, Liubov Neamtu

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3917; DOI: 10.1183/13993003.congress-2016.PA3917
Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP)
Ilaria Campo, Francesca Mariani, Elena Paracchini, Zamir Kadija, Michele Zorzetto, Carmine Tinelli, Giuseppe Rodi, Federica Meloni, Matthias Griese, Bruce Trapnell, Gerhard Scheuch, Bernhard Muellinger, Maurizio Luisetti

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3870; DOI: 10.1183/13993003.congress-2016.PA3870
Eosinophilic lung disease
Samira Aouadi, Boutheina Melki, Emna Braham, Houda Gharsalli, Sonia Maâlej, Leila Douik Elgharbi

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3881; DOI: 10.1183/13993003.congress-2016.PA3881
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Katrin Esther Hostettler Haack, Jörg Halter, Michael Tamm

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3923; DOI: 10.1183/13993003.congress-2016.PA3923

Main menu

User menu

Search

More articles from 1.5 Diffuse Parenchymal Lung Disease

Pages

Contact us